使用Player FM应用程序离线!
102: DigiPath Digest #10 (From HER2 Low to Gleason Grading: AI in Digital Pathology Research)
Manage episode 437106771 series 3404634
Welcome to the 10th edition of the DigiPath Digest. Today, we discuss essential updates including the free availability of my 'Digital Pathology 101' book and the podcast now accessible on YouTube and YouTube Music. We dive deep into the weekly abstract, focusing on advancements such as sex-specific histopathological models for gliomas, leukocyte identification tools, and automated Gleason grading for prostate cancer. We also explore the potential of SciSpace, an AI tool for interacting with scientific papers. Interspersed with live interaction, we discuss the importance of consistency in histopathological grading and the challenges faced by pathologists. J
00:00 Introduction and Announcements
00:55 Live Interaction and Updates
05:01 Abstract Review: High-Grade Gliomas
11:45 Abstract Review: Leukocyte Identification Tool
13:24 Abstract Review: Gleason Grading in Prostate Cancer
16:31 Abstract Review: HER2 Low Prediction in Breast Cancer
24:01 Event Announcements and Closing Remarks
THIS EPISODES RESOURCES:
📰 Sexually dimorphic computational histopathological signatures prognostic of overall survival in high-grade gliomas via deep learning
🔗https://pubmed.ncbi.nlm.nih.gov/39178259/
📰 A Digital Tool Supporting Pathology Practice and Identifying Leucocytes
🔗https://pubmed.ncbi.nlm.nih.gov/39176939/
📰 Assessing the Performance of Deep Learning for Automated Gleason Grading in Prostate Cancer
🔗https://pubmed.ncbi.nlm.nih.gov/39176576/
📰 Weakly-supervised deep learning models enable HER2-low prediction from H &E stained slides
🔗https://pubmed.ncbi.nlm.nih.gov/39160593/
▶️ YouTube Version of this Episode:
🔗 https://www.youtube.com/live/06QXmwojxDE?si=q59PjGkHbXCUFhwI
📕 Digital Pathology 101 E-book
🔗https://digitalpathology.club/digital-pathology-beginners-guide-notification
Show less
Become a Digital Pathology Trailblazer get the "Digital Pathology 101" FREE E-book and join us!
119集单集
Manage episode 437106771 series 3404634
Welcome to the 10th edition of the DigiPath Digest. Today, we discuss essential updates including the free availability of my 'Digital Pathology 101' book and the podcast now accessible on YouTube and YouTube Music. We dive deep into the weekly abstract, focusing on advancements such as sex-specific histopathological models for gliomas, leukocyte identification tools, and automated Gleason grading for prostate cancer. We also explore the potential of SciSpace, an AI tool for interacting with scientific papers. Interspersed with live interaction, we discuss the importance of consistency in histopathological grading and the challenges faced by pathologists. J
00:00 Introduction and Announcements
00:55 Live Interaction and Updates
05:01 Abstract Review: High-Grade Gliomas
11:45 Abstract Review: Leukocyte Identification Tool
13:24 Abstract Review: Gleason Grading in Prostate Cancer
16:31 Abstract Review: HER2 Low Prediction in Breast Cancer
24:01 Event Announcements and Closing Remarks
THIS EPISODES RESOURCES:
📰 Sexually dimorphic computational histopathological signatures prognostic of overall survival in high-grade gliomas via deep learning
🔗https://pubmed.ncbi.nlm.nih.gov/39178259/
📰 A Digital Tool Supporting Pathology Practice and Identifying Leucocytes
🔗https://pubmed.ncbi.nlm.nih.gov/39176939/
📰 Assessing the Performance of Deep Learning for Automated Gleason Grading in Prostate Cancer
🔗https://pubmed.ncbi.nlm.nih.gov/39176576/
📰 Weakly-supervised deep learning models enable HER2-low prediction from H &E stained slides
🔗https://pubmed.ncbi.nlm.nih.gov/39160593/
▶️ YouTube Version of this Episode:
🔗 https://www.youtube.com/live/06QXmwojxDE?si=q59PjGkHbXCUFhwI
📕 Digital Pathology 101 E-book
🔗https://digitalpathology.club/digital-pathology-beginners-guide-notification
Show less
Become a Digital Pathology Trailblazer get the "Digital Pathology 101" FREE E-book and join us!
119集单集
所有剧集
×欢迎使用Player FM
Player FM正在网上搜索高质量的播客,以便您现在享受。它是最好的播客应用程序,适用于安卓、iPhone和网络。注册以跨设备同步订阅。